These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 34056918

  • 21. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.
    Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R.
    Basic Res Cardiol; 2010 Nov; 105(6):771-85. PubMed ID: 20960209
    [Abstract] [Full Text] [Related]

  • 22. Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats.
    Tai H, Jiang XL, Lan ZM, Li Y, Kong L, Yao SC, Song N, Lv MJ, Wu J, Yang P, Xiao XS, Yang GL, Kuang JS, Jia LQ.
    BMC Complement Med Ther; 2021 Mar 22; 21(1):100. PubMed ID: 33752661
    [Abstract] [Full Text] [Related]

  • 23. Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction.
    Bakhta O, Blanchard S, Guihot AL, Tamareille S, Mirebeau-Prunier D, Jeannin P, Prunier F.
    J Cardiovasc Pharmacol Ther; 2018 Sep 22; 23(5):446-455. PubMed ID: 29658326
    [Abstract] [Full Text] [Related]

  • 24. Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
    Panel M, Ruiz I, Brillet R, Lafdil F, Teixeira-Clerc F, Nguyen CT, Calderaro J, Gelin M, Allemand F, Guichou JF, Ghaleh B, Ahmed-Belkacem A, Morin D, Pawlotsky JM.
    Gastroenterology; 2019 Nov 22; 157(5):1368-1382. PubMed ID: 31336123
    [Abstract] [Full Text] [Related]

  • 25. Synergistic protective effect of cyclosporin A and rotenone against hypoxia-reoxygenation in cardiomyocytes.
    Teixeira G, Abrial M, Portier K, Chiari P, Couture-Lepetit E, Tourneur Y, Ovize M, Gharib A.
    J Mol Cell Cardiol; 2013 Mar 22; 56():55-62. PubMed ID: 23238221
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Enhanced cell-volume regulation in cyclosporin A cardioprotection.
    Diaz RJ, Fernandes K, Lytvyn Y, Hawrylyshyn K, Harvey K, Hossain T, Hinek A, Wilson GJ.
    Cardiovasc Res; 2013 Jun 01; 98(3):411-9. PubMed ID: 23483048
    [Abstract] [Full Text] [Related]

  • 29. The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy.
    Rees PS, Davidson SM, Harding SE, McGregor C, Elliot PM, Yellon DM, Hausenloy DJ.
    Cardiovasc Drugs Ther; 2013 Jun 01; 27(3):235-7. PubMed ID: 23380984
    [No Abstract] [Full Text] [Related]

  • 30. The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species.
    Stroethoff M, Goetze L, Torregroza C, Bunte S, Raupach A, Heinen A, Mathes A, Hollmann MW, Huhn R.
    Cardiovasc Drugs Ther; 2020 Jun 01; 34(3):303-310. PubMed ID: 32236860
    [Abstract] [Full Text] [Related]

  • 31. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N.
    Cardiovasc Ther; 2017 Oct 01; 35(5):. PubMed ID: 28726291
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inhibition of programmed necrosis limits infarct size through altered mitochondrial and immune responses in the aged female rat heart.
    Garvin AM, Jackson MA, Korzick DH.
    Am J Physiol Heart Circ Physiol; 2018 Nov 01; 315(5):H1434-H1442. PubMed ID: 29957016
    [Abstract] [Full Text] [Related]

  • 35. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H, Zhao YT, Zhang S, Dubielecka PM, Du J, Yano N, Chin YE, Zhuang S, Qin G, Zhao TC.
    J Cell Physiol; 2017 Dec 01; 232(12):3775-3785. PubMed ID: 28181692
    [Abstract] [Full Text] [Related]

  • 36. Cyclophilin D-mediated regulation of the permeability transition pore is altered in mice lacking the mitochondrial calcium uniporter.
    Parks RJ, Menazza S, Holmström KM, Amanakis G, Fergusson M, Ma H, Aponte AM, Bernardi P, Finkel T, Murphy E.
    Cardiovasc Res; 2019 Feb 01; 115(2):385-394. PubMed ID: 30165576
    [Abstract] [Full Text] [Related]

  • 37. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
    Ananthakrishnan R, Kaneko M, Hwang YC, Quadri N, Gomez T, Li Q, Caspersen C, Ramasamy R.
    Am J Physiol Heart Circ Physiol; 2009 Feb 01; 296(2):H333-41. PubMed ID: 19060123
    [Abstract] [Full Text] [Related]

  • 38. Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.
    Bajpai G, Bredemeyer A, Li W, Zaitsev K, Koenig AL, Lokshina I, Mohan J, Ivey B, Hsiao HM, Weinheimer C, Kovacs A, Epelman S, Artyomov M, Kreisel D, Lavine KJ.
    Circ Res; 2019 Jan 18; 124(2):263-278. PubMed ID: 30582448
    [Abstract] [Full Text] [Related]

  • 39. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
    Schriewer JM, Peek CB, Bass J, Schumacker PT.
    J Am Heart Assoc; 2013 Apr 18; 2(2):e000159. PubMed ID: 23598272
    [Abstract] [Full Text] [Related]

  • 40. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
    Townsend PA, Davidson SM, Clarke SJ, Khaliulin I, Carroll CJ, Scarabelli TM, Knight RA, Stephanou A, Latchman DS, Halestrap AP.
    Am J Physiol Heart Circ Physiol; 2007 Aug 18; 293(2):H928-38. PubMed ID: 17483234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.